Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03554473
Title M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

lung small cell carcinoma


M7824 + Topotecan

M7824 + Temozolomide


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.